New Zealand markets close in 1 hour 44 minutes
  • NZX 50

    10,931.20
    +68.86 (+0.63%)
     
  • NZD/USD

    0.6217
    +0.0005 (+0.07%)
     
  • NZD/EUR

    0.5959
    +0.0005 (+0.09%)
     
  • ALL ORDS

    6,811.10
    +14.20 (+0.21%)
     
  • ASX 200

    6,624.30
    +11.70 (+0.18%)
     
  • OIL

    110.28
    +1.85 (+1.71%)
     
  • GOLD

    1,810.30
    +8.80 (+0.49%)
     
  • NASDAQ

    11,585.68
    +81.98 (+0.71%)
     
  • FTSE

    7,232.65
    +64.00 (+0.89%)
     
  • Dow Jones

    31,097.26
    +321.86 (+1.05%)
     
  • DAX

    12,773.38
    -39.65 (-0.31%)
     
  • Hang Seng

    21,891.94
    +61.59 (+0.28%)
     
  • NIKKEI 225

    26,369.24
    +215.43 (+0.82%)
     
  • NZD/JPY

    84.6420
    +0.4030 (+0.48%)
     

ECG Devices Global Market Report 2022

·3-min read
ReportLinker
ReportLinker

Major players in the ECG devices market are GE Healthcare, Koninklijke Philips N. V, Spacelabs Healthcare, CardioNet Inc, Schiller AG, Nihon Kohden Corporation, Medtronic PLC, OSI Systems, Mindray Medical International Limited, and Hill-Rom Holdings Inc.

New York, May 24, 2022 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "ECG Devices Global Market Report 2022" - https://www.reportlinker.com/p06280883/?utm_source=GNW


The global ecg devices market is expected to grow from $4.62 billion in 2021 to $4.99 billion in 2022 at a compound annual growth rate (CAGR) of 8%. The market is expected to grow to $7.04 billion in 2026 at a compound annual growth rate (CAGR) of 9%.

The ECG devices market consists of sales of ECG devices by entities (organizations, sole traders, and partnerships) that are used to record heart activities through electric signals and are amplified on the ECG monitor.The devices are used to diagnose various types of heart diseases and arrhythmias in a person’s body, therefore, assisting the relevant therapy.

The market consists of revenue generated by the companies manufacturing the ECG devices.

The main types of ECG devices are monitoring ECG systems and diagnostic ECG systems.Monitoring ECG systems record the electrical signal of the heart to check for different heart conditions.

The various technology involved is portable ECG systems and wireless ECG systems.The various lead types involved are single-lead ECG, 3-6 lead ECG, and 12-Lead ECG.

The various end-users involved are hospitals, home care settings, and others.

The increasing incidence of cardiovascular diseases is expected to boost the demand for the ECG devices market over the coming years.Cardiovascular disease is one of the most common of all health problems and the leading cause of death globally.

To check for various cardiac diseases, an electrocardiogram (ECG or EKG) measures the electrical signal from the heart.Electrodes are set on the chest to record the electrical signals sent by the heart, which cause it to beat.

According to the Centers for Disease Control and Prevention, heart disease is the major cause of death in the USA, accounting for almost 647,000 deaths per year. Moreover, according to the American Heart Association, 2019, around 121.5 million adults in the USA have some form of cardiovascular disease. Thus, increasing cardiovascular diseases such as hypertensive heart disease, stroke, peripheral artery diseases, and ischemic heart disease (IHD) drive the growth of the ECG devices market.

The launch of advanced ECG devices is shaping the ECG devices market.Major companies operating in the ECG devices sector are focused on developing technological solutions for ECG devices to strengthen their position.

For instance, in September 2020, AliveCor, a US FDA-cleared personal electrocardiogram (ECG) technology company launched a clinically validated personal ECG device based on KardiaMobile 6L technology.In just 30 seconds, individuals can record a medical-grade ECG using this device.

It is small enough to slip into a pocket. Users can use their smartphones to monitor their heartbeats.

In December 2020, Philips, a Europe-based health technology company acquired BioTelemetry for $2.8 billion (approx. EUR 2.3 billion). The acquisition of BioTelemetry fits well with Philips’ cardiac care portfolio and its strategy to transform care delivery across the health continuum with integrated solutions. BioTelemetry, Inc is a U.S.-based company that provides heart monitoring devices.

The regions covered in this report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.

The countries covered in the ECG devices market are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA.

Read the full report: https://www.reportlinker.com/p06280883/?utm_source=GNW

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________

CONTACT: Clare: clare@reportlinker.com US: (339)-368-6001 Intl: +1 339-368-6001


Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting